These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21978994)

  • 21. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.
    Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C
    Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-molecule imaging reveals aβ42:aβ40 ratio-dependent oligomer growth on neuronal processes.
    Johnson RD; Schauerte JA; Chang CC; Wisser KC; Althaus JC; Carruthers CJ; Sutton MA; Steel DG; Gafni A
    Biophys J; 2013 Feb; 104(4):894-903. PubMed ID: 23442968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.
    Roselli F; Tirard M; Lu J; Hutzler P; Lamberti P; Livrea P; Morabito M; Almeida OF
    J Neurosci; 2005 Nov; 25(48):11061-70. PubMed ID: 16319306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer's Disease Patients.
    Sancesario GM; Nuccetelli M; Cerri A; Zegeer J; Severini C; Ciotti MT; Pieri M; Martorana A; Caltagirone C; Nistico R; Bernardini S
    Curr Alzheimer Res; 2018; 15(7):628-636. PubMed ID: 29359669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
    Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
    J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of amyloid-β peptide on synaptic plasticity and memory is influenced by different isoforms, concentrations, and aggregation status.
    Gulisano W; Melone M; Li Puma DD; Tropea MR; Palmeri A; Arancio O; Grassi C; Conti F; Puzzo D
    Neurobiol Aging; 2018 Nov; 71():51-60. PubMed ID: 30092511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid.
    Marsh J; Bagol SH; Williams RSB; Dickson G; Alifragis P
    Neurobiol Dis; 2017 Oct; 106():63-75. PubMed ID: 28647556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APP homodimers transduce an amyloid-β-mediated increase in release probability at excitatory synapses.
    Fogel H; Frere S; Segev O; Bharill S; Shapira I; Gazit N; O'Malley T; Slomowitz E; Berdichevsky Y; Walsh DM; Isacoff EY; Hirsch JA; Slutsky I
    Cell Rep; 2014 Jun; 7(5):1560-1576. PubMed ID: 24835997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aβ(39-42) modulates Aβ oligomerization but not fibril formation.
    Gessel MM; Wu C; Li H; Bitan G; Shea JE; Bowers MT
    Biochemistry; 2012 Jan; 51(1):108-17. PubMed ID: 22129303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Mode of Action of an Anti-Oligomeric Amyloid β-Protein Antibody Affects its Protective Efficacy.
    Zhang Y; Huai Y; Zhang X; Song C; Cai J; Zhang Y
    Neurotox Res; 2019 Feb; 35(2):304-317. PubMed ID: 30229545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of different amyloid β-protein analogues on synaptic function.
    Ripoli C; Piacentini R; Riccardi E; Leone L; Li Puma DD; Bitan G; Grassi C
    Neurobiol Aging; 2013 Apr; 34(4):1032-44. PubMed ID: 23046860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and function.
    Barucker C; Bittner HJ; Chang PK; Cameron S; Hancock MA; Liebsch F; Hossain S; Harmeier A; Shaw H; Charron FM; Gensler M; Dembny P; Zhuang W; Schmitz D; Rabe JP; Rao Y; Lurz R; Hildebrand PW; McKinney RA; Multhaup G
    Sci Rep; 2015 Oct; 5():15410. PubMed ID: 26510576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different electrophysiological actions of 24- and 72-hour aggregated amyloid-beta oligomers on hippocampal field population spike in both anesthetized and awake rats.
    Orbán G; Völgyi K; Juhász G; Penke B; Kékesi KA; Kardos J; Czurkó A
    Brain Res; 2010 Oct; 1354():227-35. PubMed ID: 20659435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure.
    Yin Y; Zhao Y; Han S; Zhang N; Chen H; Wang X
    J Alzheimers Dis; 2017; 59(3):851-869. PubMed ID: 28697568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number.
    Xu S; Liu G; Bao X; Wu J; Li S; Zheng B; Anwyl R; Wang Q
    J Alzheimers Dis; 2014; 39(2):239-51. PubMed ID: 24150104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockers.
    Hermann D; Mezler M; Müller MK; Wicke K; Gross G; Draguhn A; Bruehl C; Nimmrich V
    Eur J Pharmacol; 2013 Feb; 702(1-3):44-55. PubMed ID: 23376566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates.
    Zhang X; Huai Y; Cai J; Song C; Zhang Y
    Int Immunopharmacol; 2019 Feb; 67():176-185. PubMed ID: 30553911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-terminal turn stability determines assembly differences between Aβ40 and Aβ42.
    Roychaudhuri R; Yang M; Deshpande A; Cole GM; Frautschy S; Lomakin A; Benedek GB; Teplow DB
    J Mol Biol; 2013 Jan; 425(2):292-308. PubMed ID: 23154165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.